サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1241279

抗体薬物複合体受託製造の世界市場：考察と予測 (2028年まで)

Global Antibody Drug Conjugates Contract Manufacturing Market Insights, Forecast to 2028
出版日: | 発行: QYResearch | ページ情報: 英文 151 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
抗体薬物複合体受託製造の世界市場：考察と予測 (2028年まで)
出版日: 2023年03月22日
発行: QYResearch
ページ情報: 英文 151 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の抗体薬物複合体受託製造の市場規模は、COVID-19パンデミックとロシア・ウクライナ戦争の影響により、2023年に33億131万米ドル、2029年までに93億3,376万米ドルの改定規模に達し、予測期間中 (2023年～2029年) に18.91%のCAGRで成長する、と予測されます。

米国・カナダの抗体薬物複合体受託製造の市場規模は、2023年の11億8,154万米ドルから、2029年には36億9,897万米ドルに達し、予測期間中 (2024年～2029年) に20.95%のCAGRで成長する、と予測されます。

中国の抗体薬物複合体受託製造の市場規模は、2023年の4億2,257万米ドルから、2029年には11億3,592万米ドルに達し、予測期間中 (2024年～2029年) に17.92%のCAGRで成長する、と予測されています。

欧州の抗体薬物複合体受託製造の市場規模は、2023年の9億2,437万米ドルから、2029年には26億2,559万米ドルに達し、予測期間中 (2024年～2029年) に19%のCAGRで成長する、とされています。

当レポートでは、世界の抗体薬物複合体受託製造の市場について分析し、種類別・用途別・地域別 (国別) の市場動向の見通し (2018年～2029年)、主要企業のプロファイルなどについて調査しております。

目次

第1章 調査概要

  • 調査範囲
  • 種類別の市場分析
    • 市場規模・成長率：種類別 (2018年・2022年・2029年)
    • IgG1
    • IgG4
  • 用途別の市場
    • 市場シェア：用途別 (2018年・2022年・2029年)
    • 固形腫瘍
    • 悪性血液腫瘍
  • 前提・制約条件
  • 分析対象
  • 分析期間

第2章 世界の成長動向

  • 世界の抗体薬物複合体受託製造市場の展望 (2018年～2029年)
  • 抗体薬物複合体受託製造の成長動向：地域別
  • 抗体薬物複合体受託製造の市場力学

第3章 主要企業別の競合情勢

  • 世界の抗体薬物複合体受託製造の収益：企業別
  • 市場シェア：企業の種類別 (ティア1、ティア2、ティア3)
  • 分析対象企業：抗体薬物複合体受託製造の収益別のランキング (2021年・2022年・2023年)
  • 世界の抗体薬物複合体受託製造市場の集中度
  • 抗体薬物複合体受託製造の主要企業：本社・提供エリア
  • 抗体薬物複合体受託製造の主要企業：製品とその用途
  • 抗体薬物複合体受託製造の主要企業：設立時期

第4章 抗体薬物複合体受託製造：種類別の内訳データ

  • 過去の市場規模：種類別 (2018年～2023年)
  • 市場規模の予測：種類別 (2024年～2029年)

第5章 抗体薬物複合体受託製造：用途別の内訳データ

  • 過去の市場規模：用途別 (2018年～2023年)
  • 市場規模の予測：用途別 (2024年～2029年)

第6章 北米

  • 北米の抗体薬物複合体受託製造の市場規模 (2018年～2029年)
  • 北米の抗体薬物複合体受託製造の市場規模：種類別
  • 北米の抗体薬物複合体受託製造の市場規模：用途別
  • 北米の抗体薬物複合体受託製造の市場規模：国別
    • 米国
    • カナダ

第7章 欧州

  • 欧州の抗体薬物複合体受託製造の市場規模 (2018年～2029年)
  • 欧州の抗体薬物複合体受託製造の市場規模：種類別
  • 欧州の抗体薬物複合体受託製造の市場規模：用途別
  • 欧州の抗体薬物複合体受託製造の市場規模：国別
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア
    • 北欧諸国

第8章 中国

  • 中国の抗体薬物複合体受託製造の市場規模 (2018年～2029年)
  • 中国の抗体薬物複合体受託製造の市場規模：種類別
  • 中国の抗体薬物複合体受託製造の市場規模：用途別

第9章 アジア (中国以外)

  • アジアの抗体薬物複合体受託製造の市場規模 (2018年～2029年)
  • アジアの抗体薬物複合体受託製造の市場規模：種類別
  • アジアの抗体薬物複合体受託製造の市場規模：用途別
  • アジアの抗体薬物複合体受託製造の市場規模：地域別
    • 日本
    • 韓国
    • 台湾
    • 東南アジア
    • インド
    • オーストラリア

第10章 中東・アフリカ・ラテンアメリカ

  • 中東・アフリカ・ラテンアメリカの抗体薬物複合体受託製造の市場規模 (2018年～2029年)
  • 中東・アフリカ・ラテンアメリカの抗体薬物複合体受託製造の市場規模：種類別
  • 中東・アフリカ・ラテンアメリカの抗体薬物複合体受託製造の市場規模：用途別
  • 中東・アフリカ・ラテンアメリカの抗体薬物複合体受託製造の市場規模：国別
    • ブラジル
    • メキシコ
    • トルコ
    • イスラエル
    • GCC諸国

第11章 主要企業のプロファイル

  • Lonza Group
  • Merck
  • Recipharm
  • Thermo Fisher Scientific
  • Abbvie
  • Piramal Pharma Solutions
  • Catalent
  • Sterling Pharma Solutions
  • Curia
  • Novasep
  • Ajinomoto Bio-Pharma Services
  • BSP Pharmaceuticals
  • Cerbios-Pharma
  • GBI (Goodwin Biotechnology)

第12章 アナリストの見解/結論

第13章 付録

図表

List of Tables

  • Table 1. Global Antibody Drug Conjugates Contract Manufacturing Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
  • Table 2. Key Players of IgG1
  • Table 3. Key Players of IgG4
  • Table 4. Global Antibody Drug Conjugates Contract Manufacturing Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
  • Table 5. Global Antibody Drug Conjugates Contract Manufacturing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
  • Table 6. Global Antibody Drug Conjugates Contract Manufacturing Market Size by Region (2018-2023) & (US$ Million)
  • Table 7. Global Antibody Drug Conjugates Contract Manufacturing Market Share by Region (2018-2023)
  • Table 8. Global Antibody Drug Conjugates Contract Manufacturing Forecasted Market Size by Region (2024-2029) & (US$ Million)
  • Table 9. Global Antibody Drug Conjugates Contract Manufacturing Market Share by Region (2024-2029)
  • Table 10. Global Antibody Drug Conjugates Contract Manufacturing Revenue by Players (2018-2023) & (US$ Million)
  • Table 11. Global Antibody Drug Conjugates Contract Manufacturing Market Share by Players (2018-2023)
  • Table 12. Global Top Antibody Drug Conjugates Contract Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Drug Conjugates Contract Manufacturing as of 2021)
  • Table 13. Global Antibody Drug Conjugates Contract Manufacturing Industry Ranking 2021 VS 2022 VS 2023
  • Table 14. Global 5 Largest Players Market Share by Antibody Drug Conjugates Contract Manufacturing Revenue (CR5 and HHI) & (2018-2023)
  • Table 15. Global Key Players of Antibody Drug Conjugates Contract Manufacturing, Headquarters and Area Served
  • Table 16. Global Key Players of Antibody Drug Conjugates Contract Manufacturing, Product and Application
  • Table 17. Global Key Players of Antibody Drug Conjugates Contract Manufacturing, Date of Established
  • Table 18. Global Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2018-2023) & (US$ Million)
  • Table 19. Global Antibody Drug Conjugates Contract Manufacturing Revenue Market Share by Type (2018-2023)
  • Table 20. Global Antibody Drug Conjugates Contract Manufacturing Forecasted Market Size by Type (2024-2029) & (US$ Million)
  • Table 21. Global Antibody Drug Conjugates Contract Manufacturing Revenue Market Share by Type (2024-2029)
  • Table 22. Global Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2018-2023) & (US$ Million)
  • Table 23. Global Antibody Drug Conjugates Contract Manufacturing Revenue Market Share by Application (2018-2023)
  • Table 24. Global Antibody Drug Conjugates Contract Manufacturing Forecasted Market Size by Application (2024-2029) & (US$ Million)
  • Table 25. Global Antibody Drug Conjugates Contract Manufacturing Revenue Market Share by Application (2024-2029)
  • Table 26. North America Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2018-2023) & (US$ Million)
  • Table 27. North America Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2024-2029) & (US$ Million)
  • Table 28. North America Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2018-2023) & (US$ Million)
  • Table 29. North America Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2024-2029) & (US$ Million)
  • Table 30. North America Antibody Drug Conjugates Contract Manufacturing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 31. North America Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2018-2023) & (US$ Million)
  • Table 32. North America Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2024-2029) & (US$ Million)
  • Table 33. Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2018-2023) & (US$ Million)
  • Table 34. Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2024-2029) & (US$ Million)
  • Table 35. Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2018-2023) & (US$ Million)
  • Table 36. Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2024-2029) & (US$ Million)
  • Table 37. Europe Antibody Drug Conjugates Contract Manufacturing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 38. Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2018-2023) & (US$ Million)
  • Table 39. Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2024-2029) & (US$ Million)
  • Table 40. China Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2018-2023) & (US$ Million)
  • Table 41. China Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2024-2029) & (US$ Million)
  • Table 42. China Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2018-2023) & (US$ Million)
  • Table 43. China Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2024-2029) & (US$ Million)
  • Table 44. Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2018-2023) & (US$ Million)
  • Table 45. Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2024-2029) & (US$ Million)
  • Table 46. Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2018-2023) & (US$ Million)
  • Table 47. Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2024-2029) & (US$ Million)
  • Table 48. Asia Antibody Drug Conjugates Contract Manufacturing Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
  • Table 49. Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Region (2018-2023) & (US$ Million)
  • Table 50. Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Region (2024-2029) & (US$ Million)
  • Table 51. Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2018-2023) & (US$ Million)
  • Table 52. Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2024-2029) & (US$ Million)
  • Table 53. Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2018-2023) & (US$ Million)
  • Table 54. Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2024-2029) & (US$ Million)
  • Table 55. Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 56. Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2018-2023) & (US$ Million)
  • Table 57. Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2024-2029) & (US$ Million)
  • Table 58. Lonza Group Company Details
  • Table 59. Lonza Group Antibody Drug Conjugates Contract Manufacturing Product
  • Table 60. Lonza Group Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) & (US$ Million)
  • Table 61. Merck Company Details
  • Table 62. Merck Antibody Drug Conjugates Contract Manufacturing Product
  • Table 63. Merck Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) & (US$ Million)
  • Table 64. Recipharm Company Details
  • Table 65. Recipharm Antibody Drug Conjugates Contract Manufacturing Product
  • Table 66. Recipharm Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) & (US$ Million)
  • Table 67. Thermo Fisher Scientific Company Details
  • Table 68. Thermo Fisher Scientific Antibody Drug Conjugates Contract Manufacturing Product
  • Table 69. Thermo Fisher Scientific Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) & (US$ Million)
  • Table 70. Abbvie Company Details
  • Table 71. Abbvie Antibody Drug Conjugates Contract Manufacturing Product
  • Table 72. Abbvie Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) & (US$ Million)
  • Table 73. Piramal Pharma Solutions Company Details
  • Table 74. Piramal Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Product
  • Table 75. Piramal Pharma Solutions Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) & (US$ Million)
  • Table 76. Catalent Company Details
  • Table 77. Catalent Antibody Drug Conjugates Contract Manufacturing Product
  • Table 78. Catalent Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) & (US$ Million)
  • Table 79. Sterling Pharma Solutions Company Details
  • Table 80. Sterling Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Product
  • Table 81. Sterling Pharma Solutions Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) & (US$ Million)
  • Table 82. Curia Company Details
  • Table 83. Curia Antibody Drug Conjugates Contract Manufacturing Product
  • Table 84. Curia Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) & (US$ Million)
  • Table 85. Novasep Company Details
  • Table 86. Novasep Antibody Drug Conjugates Contract Manufacturing Product
  • Table 87. Novasep Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) & (US$ Million)
  • Table 88. Ajinomoto Bio-Pharma Services Company Details
  • Table 89. Ajinomoto Bio-Pharma Services Antibody Drug Conjugates Contract Manufacturing Product
  • Table 90. Ajinomoto Bio-Pharma Services Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) & (US$ Million)
  • Table 91. BSP Pharmaceuticals Company Details
  • Table 92. BSP Pharmaceuticals Antibody Drug Conjugates Contract Manufacturing Product
  • Table 93. BSP Pharmaceuticals Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) & (US$ Million)
  • Table 94. Cerbios-Pharma Company Details
  • Table 95. Cerbios-Pharma Antibody Drug Conjugates Contract Manufacturing Product
  • Table 96. Cerbios-Pharma Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) & (US$ Million)
  • Table 97. GBI (Goodwin Biotechnology) Company Details
  • Table 98. GBI (Goodwin Biotechnology) Antibody Drug Conjugates Contract Manufacturing Product
  • Table 99. GBI (Goodwin Biotechnology) Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) & (US$ Million)
  • Table 100. Research Programs/Design for This Report
  • Table 101. Key Data Information from Secondary Sources
  • Table 102. Key Data Information from Primary Sources
  • Table 103. QYR Business Unit and Senior & Team Lead Analysts

List of Figures

  • Figure 1. Global Antibody Drug Conjugates Contract Manufacturing Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 2. Global Antibody Drug Conjugates Contract Manufacturing Market Share by Type: 2022 VS 2029
  • Figure 3. Global Antibody Drug Conjugates Contract Manufacturing Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 4. Global Antibody Drug Conjugates Contract Manufacturing Market Share by Application: 2022 VS 2029
  • Figure 5. Antibody Drug Conjugates Contract Manufacturing Report Years Considered
  • Figure 6. Global Antibody Drug Conjugates Contract Manufacturing Market Size (US$ Million), Year-over-Year: 2018-2029
  • Figure 7. Global Antibody Drug Conjugates Contract Manufacturing Market Size, (US$ Million), 2018 VS 2022 VS 2029
  • Figure 8. Global Antibody Drug Conjugates Contract Manufacturing Market Share by Region: 2022 VS 2029
  • Figure 9. Global Antibody Drug Conjugates Contract Manufacturing Market Share by Players in 2022
  • Figure 10. Global Top Antibody Drug Conjugates Contract Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Drug Conjugates Contract Manufacturing as of 2022)
  • Figure 11. The Top 10 and 5 Players Market Share by Antibody Drug Conjugates Contract Manufacturing Revenue in 2022
  • Figure 12. North America Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 13. North America Antibody Drug Conjugates Contract Manufacturing Market Share by Type (2018-2029)
  • Figure 14. North America Antibody Drug Conjugates Contract Manufacturing Market Share by Application (2018-2029)
  • Figure 15. North America Antibody Drug Conjugates Contract Manufacturing Market Share by Country (2018-2029)
  • Figure 16. United States Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 17. Canada Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 18. Europe Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 19. Europe Antibody Drug Conjugates Contract Manufacturing Market Share by Type (2018-2029)
  • Figure 20. Europe Antibody Drug Conjugates Contract Manufacturing Market Share by Application (2018-2029)
  • Figure 21. Europe Antibody Drug Conjugates Contract Manufacturing Market Share by Country (2018-2029)
  • Figure 22. Germany Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 23. France Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 24. U.K. Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 25. Italy Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 26. Russia Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 27. Nordic Countries Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 28. China Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 29. China Antibody Drug Conjugates Contract Manufacturing Market Share by Type (2018-2029)
  • Figure 30. China Antibody Drug Conjugates Contract Manufacturing Market Share by Application (2018-2029)
  • Figure 31. Asia Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 32. Asia Antibody Drug Conjugates Contract Manufacturing Market Share by Type (2018-2029)
  • Figure 33. Asia Antibody Drug Conjugates Contract Manufacturing Market Share by Application (2018-2029)
  • Figure 34. Asia Antibody Drug Conjugates Contract Manufacturing Market Share by Region (2018-2029)
  • Figure 35. Japan Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 36. South Korea Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 37. China Taiwan Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 38. Southeast Asia Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 39. India Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 40. Australia Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 41. Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 42. Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Share by Type (2018-2029)
  • Figure 43. Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Share by Application (2018-2029)
  • Figure 44. Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Share by Country (2018-2029)
  • Figure 45. Brazil Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 46. Mexico Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 47. Turkey Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 48. Israel Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 49. GCC Countries Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 50. Lonza Group Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023)
  • Figure 51. Merck Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023)
  • Figure 52. Recipharm Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023)
  • Figure 53. Thermo Fisher Scientific Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023)
  • Figure 54. Abbvie Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023)
  • Figure 55. Piramal Pharma Solutions Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023)
  • Figure 56. Catalent Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023)
  • Figure 57. Sterling Pharma Solutions Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023)
  • Figure 58. Curia Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023)
  • Figure 59. Novasep Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023)
  • Figure 60. Ajinomoto Bio-Pharma Services Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023)
  • Figure 61. BSP Pharmaceuticals Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023)
  • Figure 62. Cerbios-Pharma Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023)
  • Figure 63. GBI (Goodwin Biotechnology) Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023)
  • Figure 64. Bottom-up and Top-down Approaches for This Report
  • Figure 65. Data Triangulation
  • Figure 66. Key Executives Interviewed
目次

Market Analysis and Insights:

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Antibody Drug Conjugates Contract Manufacturing estimated at US$ 3,301.31 million in the year 2023, is projected to reach a revised size of US$ 9,333.76 million by 2029, growing at a CAGR of 18.91% % during the forecast period 2023-2029.

The US & Canada market for Antibody Drug Conjugates Contract Manufacturing is estimated to increase from $ 1,181.54 million in 2023 to reach $ 3,698.97 million by 2029, at a CAGR of 20.95 % during the forecast period of 2024 through 2029.

The China market for Antibody Drug Conjugates Contract Manufacturing is estimated to increase from $ 422.57 million in 2023 to reach $ 1,135.92 million by 2029, at a CAGR of 17.92% during the forecast period of 2024 through 2029.

The Europe market for Antibody Drug Conjugates Contract Manufacturing is estimated to increase from $ 924.37 million in 2023 to reach $ 2,625.59 million by 2029, at a CAGR of 19% during the forecast period of 2024 through 2029.

The global key companies of Antibody Drug Conjugates Contract Manufacturing include: Lonza Group, Merck KGaA, Recipharm, Thermo Fisher Scientific, Abbvie, Piramal Pharma Solutions, Catalent, Sterling Pharma Solutions, and Curia, etc. In 2022, the global top five players had a share approximately 68.46 % in terms of revenue.

Report Includes

This report presents an overview of global market for Antibody Drug Conjugates Contract Manufacturing market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Antibody Drug Conjugates Contract Manufacturing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Antibody Drug Conjugates Contract Manufacturing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Antibody Drug Conjugates Contract Manufacturingrevenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Antibody Drug Conjugates Contract Manufacturing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Antibody Drug Conjugates Contract Manufacturing revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Lonza Group, Merck KGaA, Recipharm, Thermo Fisher Scientific, Abbvie, Piramal Pharma Solutions, Catalent, Sterling Pharma Solutions, and Curia, etc.

By Company

  • Lonza Group
  • Merck KGaA
  • Recipharm
  • Thermo Fisher Scientific
  • Abbvie
  • Piramal Pharma Solutions
  • Catalent
  • Sterling Pharma Solutions
  • Curia
  • Novasep
  • Ajinomoto Bio-Pharma Services
  • BSP Pharmaceuticals
  • Cerbios-Pharma
  • Goodwin Biotechnology

Segment by Type

  • IgG1
  • IgG4

Segment by Application

  • Solid Tumors
  • Hematological Malignancies

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Antibody Drug Conjugates Contract Manufacturing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Antibody Drug Conjugates Contract Manufacturing companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antibody Drug Conjugates Contract Manufacturingrevenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

Table of Contents

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Antibody Drug Conjugates Contract Manufacturing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
    • 1.2.2 IgG1
    • 1.2.3 IgG4
  • 1.3 Market by Application
    • 1.3.1 Global Antibody Drug Conjugates Contract Manufacturing Market Share by Application: 2018 VS 2022 VS 2029
    • 1.3.2 Solid Tumors
    • 1.3.3 Hematological Malignancies
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Antibody Drug Conjugates Contract Manufacturing Market Perspective (2018-2029)
  • 2.2 Global Antibody Drug Conjugates Contract Manufacturing Growth Trends by Region
    • 2.2.1 Global Antibody Drug Conjugates Contract Manufacturing Market Size by Region: 2018 VS 2022 VS 2029
    • 2.2.2 Antibody Drug Conjugates Contract Manufacturing Historic Market Size by Region (2018-2023)
    • 2.2.3 Antibody Drug Conjugates Contract Manufacturing Forecasted Market Size by Region (2024-2029)
  • 2.3 Antibody Drug Conjugates Contract Manufacturing Market Dynamics
    • 2.3.1 Antibody Drug Conjugates Contract Manufacturing Industry Trends
    • 2.3.2 Antibody Drug Conjugates Contract Manufacturing Market Drivers
    • 2.3.3 Antibody Drug Conjugates Contract Manufacturing Market Challenges

3 Competition Landscape by Key Players

  • 3.1 Global Revenue Antibody Drug Conjugates Contract Manufacturing by Players
    • 3.1.1 Global Antibody Drug Conjugates Contract Manufacturing Revenue by Players (2018-2023)
    • 3.1.2 Global Antibody Drug Conjugates Contract Manufacturing Revenue Market Share by Players (2018-2023)
  • 3.2 Global Antibody Drug Conjugates Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Global Key Players of Antibody Drug Conjugates Contract Manufacturing, Ranking by Revenue, 2021 VS 2022 VS 2023
  • 3.4 Global Antibody Drug Conjugates Contract Manufacturing Market Concentration Ratio
    • 3.4.1 Global Antibody Drug Conjugates Contract Manufacturing Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Antibody Drug Conjugates Contract Manufacturing Revenue in 2022
  • 3.5 Global Key Players of Antibody Drug Conjugates Contract Manufacturing Head office and Area Served
  • 3.6 Global Key Players of Antibody Drug Conjugates Contract Manufacturing, Product and Application
  • 3.7 Global Key Players of Antibody Drug Conjugates Contract Manufacturing, Date of Established

4 Antibody Drug Conjugates Contract Manufacturing Breakdown Data by Type

  • 4.1 Global Antibody Drug Conjugates Contract Manufacturing Historic Market Size by Type (2018-2023)
  • 4.2 Global Antibody Drug Conjugates Contract Manufacturing Forecasted Market Size by Type (2024-2029)

5 Antibody Drug Conjugates Contract Manufacturing Breakdown Data by Application

  • 5.1 Global Antibody Drug Conjugates Contract Manufacturing Historic Market Size by Application (2018-2023)
  • 5.2 Global Antibody Drug Conjugates Contract Manufacturing Forecasted Market Size by Application (2024-2029)

6 North America

  • 6.1 North America Antibody Drug Conjugates Contract Manufacturing Market Size (2018-2029)
  • 6.2 North America Antibody Drug Conjugates Contract Manufacturing Market Size by Type
    • 6.2.1 North America Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2018-2023)
    • 6.2.2 North America Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2024-2029)
    • 6.2.3 North America Antibody Drug Conjugates Contract Manufacturing Market Share by Type (2018-2029)
  • 6.3 North America Antibody Drug Conjugates Contract Manufacturing Market Size by Application
    • 6.3.1 North America Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2018-2023)
    • 6.3.2 North America Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2024-2029)
    • 6.3.3 North America Antibody Drug Conjugates Contract Manufacturing Market Share by Application (2018-2029)
  • 6.4 North America Antibody Drug Conjugates Contract Manufacturing Market Size by Country
    • 6.4.1 North America Antibody Drug Conjugates Contract Manufacturing Market Size by Country: 2018 VS 2022 VS 2029
    • 6.4.2 North America Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2018-2023)
    • 6.4.3 North America Antibody Drug Conjugates Contract Manufacturing Market Share by Country (2024-2029)
    • 6.4.4 United States
    • 6.4.5 Canada

7 Europe

  • 7.1 Europe Antibody Drug Conjugates Contract Manufacturing Market Size (2018-2029)
  • 7.2 Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Type
    • 7.2.1 Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2018-2023)
    • 7.2.2 Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2024-2029)
    • 7.2.3 Europe Antibody Drug Conjugates Contract Manufacturing Market Share by Type (2018-2029)
  • 7.3 Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Application
    • 7.3.1 Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2018-2023)
    • 7.3.2 Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2024-2029)
    • 7.3.3 Europe Antibody Drug Conjugates Contract Manufacturing Market Share by Application (2018-2029)
  • 7.4 Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Country
    • 7.4.1 Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Country: 2018 VS 2022 VS 2029
    • 7.4.2 Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2018-2023)
    • 7.4.3 Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2024-2029)
    • 7.4.4 Germany
    • 7.4.5 France
    • 7.4.6 U.K.
    • 7.4.7 Italy
    • 7.4.8 Russia
    • 7.4.9 Nordic Countries

8 China

  • 8.1 China Antibody Drug Conjugates Contract Manufacturing Market Size (2018-2029)
  • 8.2 China Antibody Drug Conjugates Contract Manufacturing Market Size by Type
    • 8.2.1 China Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2018-2023)
    • 8.2.2 China Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2024-2029)
    • 8.2.3 China Antibody Drug Conjugates Contract Manufacturing Market Share by Type (2018-2029)
  • 8.3 China Antibody Drug Conjugates Contract Manufacturing Market Size by Application
    • 8.3.1 China Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2018-2023)
    • 8.3.2 China Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2024-2029)
    • 8.3.3 China Antibody Drug Conjugates Contract Manufacturing Market Share by Application (2018-2029)

9 Asia (excluding China)

  • 9.1 Asia Antibody Drug Conjugates Contract Manufacturing Market Size (2018-2029)
  • 9.2 Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Type
    • 9.2.1 Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2018-2023)
    • 9.2.2 Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2024-2029)
    • 9.2.3 Asia Antibody Drug Conjugates Contract Manufacturing Market Share by Type (2018-2029)
  • 9.3 Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Application
    • 9.3.1 Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2018-2023)
    • 9.3.2 Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2024-2029)
    • 9.3.3 Asia Antibody Drug Conjugates Contract Manufacturing Market Share by Application (2018-2029)
  • 9.4 Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Region
    • 9.4.1 Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Region: 2018 VS 2022 VS 2029
    • 9.4.2 Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Region (2018-2023)
    • 9.4.3 Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Region (2024-2029)
    • 9.4.4 Japan
    • 9.4.5 South Korea
    • 9.4.6 China Taiwan
    • 9.4.7 Southeast Asia
    • 9.4.8 India
    • 9.4.9 Australia

10 Middle East, Africa, and Latin America

  • 10.1 Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size (2018-2029)
  • 10.2 Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Type
    • 10.2.1 Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2018-2023)
    • 10.2.2 Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2024-2029)
    • 10.2.3 Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Share by Type (2018-2029)
  • 10.3 Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Application
    • 10.3.1 Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2018-2023)
    • 10.3.2 Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2024-2029)
    • 10.3.3 Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Share by Application (2018-2029)
  • 10.4 Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Country
    • 10.4.1 Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Country: 2018 VS 2022 VS 2029
    • 10.4.2 Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2018-2023)
    • 10.4.3 Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2024-2029)
    • 10.4.4 Brazil
    • 10.4.5 Mexico
    • 10.4.6 Turkey
    • 10.4.7 Israel
    • 10.4.8 GCC Countries

11 Key Players Profiles

  • 11.1 Lonza Group
    • 11.1.1 Lonza Group Company Details
    • 11.1.2 Lonza Group Business Overview
    • 11.1.3 Lonza Group Antibody Drug Conjugates Contract Manufacturing Introduction
    • 11.1.4 Lonza Group Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023)
  • 11.2 Merck
    • 11.2.1 Merck Company Details
    • 11.2.2 Merck Business Overview
    • 11.2.3 Merck Antibody Drug Conjugates Contract Manufacturing Introduction
    • 11.2.4 Merck Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023)
  • 11.3 Recipharm
    • 11.3.1 Recipharm Company Details
    • 11.3.2 Recipharm Business Overview
    • 11.3.3 Recipharm Antibody Drug Conjugates Contract Manufacturing Introduction
    • 11.3.4 Recipharm Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023)
  • 11.4 Thermo Fisher Scientific
    • 11.4.1 Thermo Fisher Scientific Company Details
    • 11.4.2 Thermo Fisher Scientific Business Overview
    • 11.4.3 Thermo Fisher Scientific Antibody Drug Conjugates Contract Manufacturing Introduction
    • 11.4.4 Thermo Fisher Scientific Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023)
  • 11.5 Abbvie
    • 11.5.1 Abbvie Company Details
    • 11.5.2 Abbvie Business Overview
    • 11.5.3 Abbvie Antibody Drug Conjugates Contract Manufacturing Introduction
    • 11.5.4 Abbvie Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023)
  • 11.6 Piramal Pharma Solutions
    • 11.6.1 Piramal Pharma Solutions Company Details
    • 11.6.2 Piramal Pharma Solutions Business Overview
    • 11.6.3 Piramal Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Introduction
    • 11.6.4 Piramal Pharma Solutions Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023)
  • 11.7 Catalent
    • 11.7.1 Catalent Company Details
    • 11.7.2 Catalent Business Overview
    • 11.7.3 Catalent Antibody Drug Conjugates Contract Manufacturing Introduction
    • 11.7.4 Catalent Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023)
  • 11.8 Sterling Pharma Solutions
    • 11.8.1 Sterling Pharma Solutions Company Details
    • 11.8.2 Sterling Pharma Solutions Business Overview
    • 11.8.3 Sterling Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Introduction
    • 11.8.4 Sterling Pharma Solutions Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023)
  • 11.9 Curia
    • 11.9.1 Curia Company Details
    • 11.9.2 Curia Business Overview
    • 11.9.3 Curia Antibody Drug Conjugates Contract Manufacturing Introduction
    • 11.9.4 Curia Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023)
  • 11.10 Novasep
    • 11.10.1 Novasep Company Details
    • 11.10.2 Novasep Business Overview
    • 11.10.3 Novasep Antibody Drug Conjugates Contract Manufacturing Introduction
    • 11.10.4 Novasep Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023)
  • 11.11 Ajinomoto Bio-Pharma Services
    • 11.11.1 Ajinomoto Bio-Pharma Services Company Details
    • 11.11.2 Ajinomoto Bio-Pharma Services Business Overview
    • 11.11.3 Ajinomoto Bio-Pharma Services Antibody Drug Conjugates Contract Manufacturing Introduction
    • 11.11.4 Ajinomoto Bio-Pharma Services Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023)
  • 11.12 BSP Pharmaceuticals
    • 11.12.1 BSP Pharmaceuticals Company Details
    • 11.12.2 BSP Pharmaceuticals Business Overview
    • 11.12.3 BSP Pharmaceuticals Antibody Drug Conjugates Contract Manufacturing Introduction
    • 11.12.4 BSP Pharmaceuticals Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023)
  • 11.13 Cerbios-Pharma
    • 11.13.1 Cerbios-Pharma Company Details
    • 11.13.2 Cerbios-Pharma Business Overview
    • 11.13.3 Cerbios-Pharma Antibody Drug Conjugates Contract Manufacturing Introduction
    • 11.13.4 Cerbios-Pharma Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023)
  • 11.14 GBI (Goodwin Biotechnology)
    • 11.14.1 GBI (Goodwin Biotechnology) Company Details
    • 11.14.2 GBI (Goodwin Biotechnology) Business Overview
    • 11.14.3 GBI (Goodwin Biotechnology) Antibody Drug Conjugates Contract Manufacturing Introduction
    • 11.14.4 GBI (Goodwin Biotechnology) Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023)

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer